Tomi Jun

Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial

R. Sebra, M. Galsky, T. Dorff, 2023, Nature Medicine.

Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial

T. Guren, E. Massarelli, C. Cremolini, 2023, Nature medicine.